Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stakeholder perspectives on the sustainability of the United States biosimilars market.
Sullivan SD, Humphreys SZ, Fox D, Lockhart CM, Tait-Dinger A, Betancourt JD, Komorny KM, Haumschild R, Chester B, Harman M, Roth JA. Sullivan SD, et al. Among authors: lockhart cm. J Manag Care Spec Pharm. 2024 Oct;30(10):1065-1072. doi: 10.18553/jmcp.2024.24104. Epub 2024 Jul 16. J Manag Care Spec Pharm. 2024. PMID: 39012302 Free PMC article.
Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States.
Mai X, Mendelsohn AB, Marshall J, Lin ND, McDermott CL, Ko JS, Pawloski PA, Jamal-Allial A, Daniels K, McMahill-Walraven CN, Djibo DA, Lockhart CM. Mai X, et al. Among authors: lockhart cm. J Manag Care Spec Pharm. 2024 Oct;30(10):1160-1166. doi: 10.18553/jmcp.2024.30.10.1160. J Manag Care Spec Pharm. 2024. PMID: 39321121 Free PMC article.
Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance.
Zhang J, Sridhar G, Barr CE, Eichelberger B, Lockhart CM, Marshall J, Clewell J, Accortt NA, Curtis JR, Holmes C, McMahill-Walraven CN, Brown JS, Haynes K. Zhang J, et al. Among authors: lockhart cm. J Manag Care Spec Pharm. 2020 Apr;26(4):417-490. doi: 10.18553/jmcp.2020.26.4.417. J Manag Care Spec Pharm. 2020. PMID: 32223608 Free PMC article.
Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars.
Desai RJ, Kim SC, Curtis JR, Bosco JLF, Eichelberger B, Barr CE, Lockhart CM, Bradbury BD, Clewell J, Cohen HP, Gagne JJ; Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Switching Workgroup. Desai RJ, et al. Among authors: lockhart cm. Pharmacoepidemiol Drug Saf. 2020 Jul;29(7):757-769. doi: 10.1002/pds.4809. Epub 2019 Jul 12. Pharmacoepidemiol Drug Saf. 2020. PMID: 31298463 Review.
Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product.
Mendelsohn AB, Marshall J, McDermott CL, Pawloski PA, Brown JS, Lockhart CM. Mendelsohn AB, et al. Among authors: lockhart cm. Drugs Real World Outcomes. 2021 Jun;8(2):125-130. doi: 10.1007/s40801-021-00228-9. Epub 2021 Jan 30. Drugs Real World Outcomes. 2021. PMID: 33517548 Free PMC article.
28 results